Targeting
-
Meira Muscat 2025: From the role of the exchange to SWFs and debt IR
Over the past few years, the IR platform in the Middle East has been evolving quickly. Exchanges are maturing, listings are more regular and IR is moving beyond ‘results day’ toward a steadier focus on access, liquidity and clear communication. We’re seeing more structured targeting, more emphasis on guidance and capital allocation and better use of data that investors can actually work with. Sovereign funds are engaging in more targeted ways and many issuers are doing a better job of aligning the equity and debt stories. This came through clearly in Muscat. With more than 1,200 attendees in town, the…
-
Struggling for survival amid the noise: biotech webinar offers wider lessons for the IR community
While not everyone in the IR profession will be working in the environment that biotech IROs find themselves in today, everyone seemingly everywhere is battling the noise and uncertainty generated by tariff talks, geopolitical tensions and other macro headwinds. IR Impact recently sat down with Angela Bitting, senior vice president, corporate affairs at Twist Bioscience, Aron Feingold, vice president IR and corporate communications at Geron Corporation and Lynn Pieper Lewis, founder and CEO of webinar sponsor Gilmartin Group, to talk about the challenges the sector is facing. The fascinating discussion that followed is as useful to those in the broader…
-
How to build an IPO investor base that powers your future
Building a successful IR program starts with the initial listing
